INO
Price
$1.84
Change
-$0.01 (-0.54%)
Updated
Dec 20 closing price
ORMP
Price
$2.38
Change
-$0.11 (-4.42%)
Updated
Dec 20, 04:59 PM (EDT)
66 days until earnings call
Ad is loading...

INO vs ORMP

Header iconINO vs ORMP Comparison
Open Charts INO vs ORMPBanner chart's image
Inovio Pharmaceuticals
Price$1.84
Change-$0.01 (-0.54%)
Volume$1.45M
CapitalizationN/A
Oramed Pharmaceuticals
Price$2.38
Change-$0.11 (-4.42%)
Volume$2.34K
CapitalizationN/A
INO vs ORMP Comparison Chart
Loading...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INO vs. ORMP commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INO is a Hold and ORMP is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (INO: $1.84 vs. ORMP: $2.37)
Brand notoriety: INO: Notable vs. ORMP: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INO: 194% vs. ORMP: 66%
Market capitalization -- INO: $66.06M vs. ORMP: $95.94M
INO [@Biotechnology] is valued at $66.06M. ORMP’s [@Biotechnology] market capitalization is $95.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INO’s FA Score shows that 0 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • INO’s FA Score: 0 green, 5 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than INO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INO’s TA Score shows that 4 TA indicator(s) are bullish while ORMP’s TA Score has 3 bullish TA indicator(s).

  • INO’s TA Score: 4 bullish, 4 bearish.
  • ORMP’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, INO is a better buy in the short-term than ORMP.

Price Growth

INO (@Biotechnology) experienced а -20.69% price change this week, while ORMP (@Biotechnology) price change was -4.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

INO is expected to report earnings on May 08, 2024.

ORMP is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($95.9M) has a higher market cap than INO($66.1M). ORMP YTD gains are higher at: 2.597 vs. INO (-69.935). ORMP has higher annual earnings (EBITDA): 9.44M vs. INO (-109.89M). ORMP has more cash in the bank: 142M vs. INO (84.8M). ORMP has less debt than INO: ORMP (429K) vs INO (12.4M). INO has higher revenues than ORMP: INO (203K) vs ORMP (0).
INOORMPINO / ORMP
Capitalization66.1M95.9M69%
EBITDA-109.89M9.44M-1,164%
Gain YTD-69.9352.597-2,692%
P/E RatioN/A21.64-
Revenue203K0-
Total Cash84.8M142M60%
Total Debt12.4M429K2,890%
FUNDAMENTALS RATINGS
INO vs ORMP: Fundamental Ratings
INO
ORMP
OUTLOOK RATING
1..100
5072
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
67
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9884
PRICE GROWTH RATING
1..100
9849
P/E GROWTH RATING
1..100
10048
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INO's Valuation (59) in the Medical Specialties industry is in the same range as ORMP (67) in the Pharmaceuticals Other industry. This means that INO’s stock grew similarly to ORMP’s over the last 12 months.

INO's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ORMP (100) in the Pharmaceuticals Other industry. This means that INO’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's SMR Rating (84) in the Pharmaceuticals Other industry is in the same range as INO (98) in the Medical Specialties industry. This means that ORMP’s stock grew similarly to INO’s over the last 12 months.

ORMP's Price Growth Rating (49) in the Pharmaceuticals Other industry is somewhat better than the same rating for INO (98) in the Medical Specialties industry. This means that ORMP’s stock grew somewhat faster than INO’s over the last 12 months.

ORMP's P/E Growth Rating (48) in the Pharmaceuticals Other industry is somewhat better than the same rating for INO (100) in the Medical Specialties industry. This means that ORMP’s stock grew somewhat faster than INO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INOORMP
RSI
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
73%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
79%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 21 days ago
79%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
83%
Aroon
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
84%
View a ticker or compare two or three
Ad is loading...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GTLS184.834.04
+2.23%
Chart Industries
FARO26.070.44
+1.72%
FARO Technologies
DE432.495.86
+1.37%
Deere & Company
GDYN20.500.09
+0.44%
Grid Dynamics Holdings
SLS0.89-0.01
-1.11%
SELLAS Life Sciences Group

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with BPMC. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then BPMC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
-4.82%
BPMC - ORMP
44%
Loosely correlated
+1.36%
BTAI - ORMP
44%
Loosely correlated
+8.12%
INO - ORMP
44%
Loosely correlated
-0.27%
MBIO - ORMP
44%
Loosely correlated
+1.64%
VERV - ORMP
44%
Loosely correlated
+11.24%
More